scPharmaceuticals Inc [NASDAQ: SCPH] stock went on a downward path that fall over 0.00% on Monday, amounting to a one-week price decrease of less than 0.00%.
Over the last 12 months, SCPH stock rose by 60.17%. The one-year scPharmaceuticals Inc stock forecast points to a potential upside of 53.1. The average equity rating for SCPH stock is currently 2.50, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $304.36 million, with 53.29 million shares outstanding and 36.37 million shares in the current float. Compared to the average trading volume of 1.28M shares, SCPH stock reached a trading volume of 10885284 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on scPharmaceuticals Inc [SCPH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SCPH shares is $12.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SCPH stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Craig Hallum have made an estimate for scPharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 07, 2023. While these analysts kept the previous recommendation, Cowen raised their target price to Outperform. The new note on the price target was released on December 01, 2022, representing the official price target for scPharmaceuticals Inc stock. Previously, the target price had yet another raise to $14, while Jefferies analysts kept a Buy rating on SCPH stock.
SCPH Stock Performance Analysis:
scPharmaceuticals Inc [SCPH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by 0.00. With this latest performance, SCPH shares gained by 1.80% in over the last four-week period, additionally plugging by 144.40% over the last 6 months – not to mention a rise of 60.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SCPH stock in for the last two-week period is set at 64.40, with the RSI for the last a single of trading hit 0.05, and the three-weeks RSI is set at 0.11 for scPharmaceuticals Inc [SCPH]. The present Moving Average for the last 50 days of trading for this stock 5.34, while it was recorded at 5.67 for the last single week of trading, and 3.86 for the last 200 days.
Insight into scPharmaceuticals Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and scPharmaceuticals Inc [SCPH] shares currently have an operating margin of -133.16% and a Gross Margin at 68.33%. scPharmaceuticals Inc’s Net Margin is presently recorded at -183.55%.
scPharmaceuticals Inc (SCPH) Capital Structure & Debt Analysis
According to recent financial data for scPharmaceuticals Inc. ( SCPH), the Return on Equity (ROE) stands at -934.02%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -125.89%, reflecting the company’s efficiency in generating profits from its assets. Additionally, scPharmaceuticals Inc’s Return on Invested Capital (ROIC) is -297.12%, showcasing its effectiveness in deploying capital for earnings.
scPharmaceuticals Inc (SCPH) Efficiency & Liquidity Metrics
scPharmaceuticals Inc (SCPH) Efficiency & Liquidity Metrics
From an operational efficiency perspective, scPharmaceuticals Inc. (SCPH) effectively leverages its workforce, generating an average of -$559268.29 per employee. The company’s liquidity position is robust, with a Current Ratio of 3.85% and a Quick Ratio of 3.14%, indicating strong ability to cover short-term liabilities.
SCPH Stock EPS
With the latest financial reports released by the company, scPharmaceuticals Inc posted -0.37/share EPS, while the average EPS was predicted by analysts to be reported at -0.3/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.07. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SCPH.
scPharmaceuticals Inc [SCPH] Institutonal Ownership Details
There are presently around $80.35%, or 85.46%% of SCPH stock, in the hands of institutional investors. The top three institutional holders of SCPH stocks are: ORBIMED ADVISORS LLC with ownership of 5.56 million shares, which is approximately 14.2608%. RUBRIC CAPITAL MANAGEMENT LP, holding 3.52 million shares of the stock with an approximate value of $$15.33 million in SCPH stocks shares; and RUBRIC CAPITAL MANAGEMENT LP, currently with $$15.24 million in SCPH stock with ownership which is approximately 8.9891%.
